Access cutting-edge ptsd treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access ptsd specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ptsd treatment provided free
This is a Phase 2 randomized, double-blinded, placebo-controlled study that will evaluate multiple potential pharmacotherapeutic interventions for PTSD utilizing an adaptive platform trial design. Intervention C - Daridorexant will assess the safety and efficacy of daridorexant in participants with PTSD. Please see NCT05422612 for information on the S-21-02 Master Protocol.
Sponsor: Global Coalition for Adaptive Research
Check if you qualify for this ptsd clinical trial in Phoenix, AZ
If you're searching for ptsd treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ptsd specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.